A small study evaluated whether the use of 2 anti-inflammatories, namilumab and infliximab, could improve outcomes for patients with COVID-19 pneumonia.
All articles by Bryant Moeller
How reliable are the 10 most popular consumer pulse oximeters used for home monitoring?
An Iranian study assessed whether HScores predicted outcomes in severe COVID-19 and could thus be used to guide early treatment decisions.
Using a cohort of healthcare workers, researchers identified ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein.
The prospective SATICOVID19 study provides a detailed analysis of characteristics of invasively ventilated patients with COVID-19 in 63 ICUs in Argentina.
Analysis of 10 years of data revealed that racial and ethnic minorities experienced more adverse outcomes from severe influenza.
A large, retrospective study compared the asthma control effectiveness of once-daily fluticasone furoate/vilanterol vs twice-daily budesonide/formoterol.
In this study, the researchers explored the potential interaction between genetic risk and chronic obstructive pulmonary disease in relation to severe COVID-19.
Patients with treatment-refractory Mycobacterium avium complex (MAC) lung disease who received amikacin liposome inhalation suspension and guideline therapy had increased culture conversion compared with guideline therapy alone.
Patient-directed prone positioning is not feasible in spontaneously breathing, nonintubated patients hospitalized with COVID-19.
Patients with bronchiectasis on long term macrolide therapy were at low risk of developing macrolide-resistant Mycobacterium avium complex (MAC) disease.
An existing virtual transition and recovery program for patients with sepsis may be used as a model for similar programs for COVID-19 survivors.
High levels of anxiety are a risk factor for loss of asthma control and decline in disease-related quality of life.
Critically ill patients with COVID-19 who experience concurrent pulmonary embolism do not have increased mortality compared with patients without pulmonary embolism.
In older adults coming to the emergency department with COVID-19, delirium was common and often presented without other typical symptoms or signs.
Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality.
Patients with severe COVID-19 pneumonia had improved prognosis after receiving a short course of methyl-prednisolone pulses during the second week of disease.
Systemic complement activation is associated with respiratory failure in patients with coronavirus disease 2019.
Patients hospitalized with COVID-19 and moderate to severe ARDS who were treated with dexamethasone experienced more ventilator-free days compared to standard care.
People with asthma were not overrepresented in patients with severe pneumonia because of SARS-CoV-2 infection who required hospitalization.
Younger patients with asthma who were hospitalized with COVID-19 did not have worse outcomes than patients hospitalized with COVID-19 without asthma.
Patients with hypoxemic acute respiratory failure because of COVID-19 who received CPAP therapy had a high failure rate during prone/lateral positioning tests.
Hospitalized patients withCOVID-19 had higher proportions of nonproductive cough, fatigue, and gastrointestinal symptoms as well as lower severity of illness scores compared with patients with H1N1 influenza.
Cavitation, low density areas, and stenosis of responsible bronchus are risk factors for infectious complications after endobronchial ultrasound-guided transbronchial biopsy.
Individuals with HIV were more likely to have interstitial lung abnormalities and findings suspicious for the presence of interstitial lung disease than individuals without HIV.
Several risk factors were identified for bronchiectasis progression in patients with COPD.
Patients with both COPD and chronic bacterial infection who had <100 circulating eosinophils/µL were at high risk of developing pneumonia.
Children with neurologic impairment had lower rates of recurrent severe pneumonia if they practiced dental care as a preventive measure.
Mycoplasma pneumoniae immunoglobulin M antibody-secreting cells were successfully used to differentiate between those with M pneumoniae infection and carriers in a pediatric population.
Patients who either are currently or have recently taken benzodiazepines may have an increased risk for pneumonia.